Login
$ATNM
$1.40 -$0.12 (7.89%) Close

$ATNM 3 SEC Filings

Filed On Filing
16 Oct 2026 Form 3: David Matthew T, Chief Financial Officer

No securities owned

10 Sep 2026 Form 3: Heeger Steffen Wilhem, Chief Medical Officer

Holds 153,868 shares of Common Stock

10 Sep 2026 Form 3: Kamal Adeela, Chief Scientific Officer

Holds 213,648 shares of Common Stock

05 Nov 2024 Form 3: Almenoff June Sherie, Director

No securities owned

01 May 2018 Form 3: Chell Jeffrey W., Director
08 Feb 2018 Form 3: Kapur Anil, Chief Commercial Officer

Holds 40,000 shares of Common Stock

09 Jan 2018 Form 3: Ludwig Dale L., Chief Scientific Officer
19 Jun 2017 Form 3: Ray Nitya G., Executive Vice President
17 May 2017 Form 3: O'Loughlin Steve, VP, Finance and Corporate Dev.
28 Mar 2017 Form 3: Shetty Ajit, Director
16 Mar 2017 Form 3: Berger Mark Stanley, Chief Medical Officer
17 Mar 2015 Form 3: Nicholson, C. David, Director

Holds 10,000 shares of Restricted Stock

13 Nov 2013 Form 3: Steinhart Richard I, Director

Holds 0 shares of Common Stock

18 Sep 2013 Form 3: Dave Kaushik J, Director

Holds 100,000 shares of Common Stock

18 Jan 2013 Form 3: Memorial Sloan-Kettering Cancer Center, 10% owner and 1 other

Holds 5,702,387 shares of Common Stock, par value $0.01 per share

07 Jan 2013 Form 3: Seth Sandesh, Director

Holds 0 shares of Common Stock

03 Jan 2013 Form 3: Talley John V., Director

Holds 0 shares of Common Stock

03 Jan 2013 Form 3: Cicic Dragan, COO and CMO

Holds 0 shares of Common Stock

03 Jan 2013 Form 3: Traversa Sergio, Director

Holds 0 shares of Common Stock

02 Jan 2013 Form 3: Mazanet Rosemary, Director

Holds 0 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support